Handono B

No ORCID on file · 1 paper in corpus · active 2023
2023
Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors.
Clinical and translational science ·doi:10.1111/cts.13603

Increasing demand for glutaminase (GLS) due to high rates of glutamine metabolism is considered one of the hallmarks of malignancy. In parallel, cancer antigen 125 (CA-125) is a commonly used ovarian tumor marker. This study aimed to compar…